Temozolomide in Treating Patients With Progressive Low-Grade Glioma

NCT00003466 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: temozolomide

Sponsor

Duke University

Collaborators

[object Object]